Quantbot Technologies’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-300
Closed -$5K 1742
2019
Q3
$5K Buy
+300
New +$3.43K ﹤0.01% 1210
2018
Q3
Sell
-3,428
Closed -$54K 1680
2018
Q2
$54K Buy
+3,428
New +$52.1K ﹤0.01% 978
2018
Q1
Sell
-1,842
Closed -$21K 1645
2017
Q4
$21K Buy
+1,842
New +$20.6K ﹤0.01% 1068
2017
Q3
Sell
-4,696
Closed -$53K 1537
2017
Q2
$53K Buy
+4,696
New +$86.8K 0.01% 897
2016
Q2
Sell
-7,910
Closed -$193K 1492
2016
Q1
$193K Buy
7,910
+6,125
+343% +$142K 0.03% 544
2015
Q4
$58K Buy
+1,785
New +$60.4K 0.01% 772

Quantbot Technologies's ALDR Position: Q4 2019 in Review

Quantbot Technologies sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 300 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in ALDR in Q4 2015 and held it in 6 quarters. The position peaked at $193K in Q1 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Quantbot Technologies reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantbot Technologies sold 300 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5K.
  • Quantbot Technologies first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 6 quarters.
  • Quantbot Technologies's Alder Biopharmaceuticals position peaked at $193K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.